Which study is right? Investigating the impact of screening on breast cancer mortality
A splashy headline in The Washington Post caught my attention: “Breast cancer death rate dropped 58 percent over 44 years in U.S.” A Stanford Medicine news story reports that this victorious conclusion is based on “a new multicenter study led by Stanford Medicine clinicians and biomedical data scientists.” Using observational data, clinical trial data, and simulation modeling, the researchers
Read more…
Which study is right? Investigating the impact of screening on breast cancer mortality originally appeared in KevinMD.com.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Shannon Casey, PA-C Tags: Conditions Oncology/Hematology Source Type: blogs
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Hematology | Study